A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 6, 2013, Pages 493-501

  Theunissen, E L ^a   Street, D ^b   Hojer A M ^b   Vermeeren, A ^a   Van Oers, A ^a   Ramaekers, J G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; VORTIOXETINE;

ADULT; ALERTNESS; ARTICLE; ATTENTION; COGNITION; COMMON COLD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DRUG BLOOD LEVEL; DRUG INDUCED HEADACHE; EVENING DOSAGE; FATIGUE; FEMALE; HUMAN; INCREASED APPETITE; INFLUENZA; MALE; MEMORY; MENSTRUAL PAIN; NAUSEA; PAIN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SLEEP DISORDER; SLEEP TIME; SOMNOLENCE; STOMACH PAIN; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS; AUTOMOBILE DRIVING; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIANSERIN; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; SULFIDES;

EID: 84878256637     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.39     Document Type: Article

References (41)

1. Ramaekers, J.G. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J. Clin. Psychiatry 64, 20-29 (2003).
2. Amado-Boccara, I., Gougoulis, N., Poirier Littré, M.F., Galinowski, A. & Lôo, H. Efects of antidepressants on cognitive functions: a review. Neurosci. Biobehav. Rev. 19, 479-493 (1995).
3. Austin, M.P., Mitchell, P. & Goodwin, G.M. Cognitive defcits in depression: possible implications for functional neuropathology. Br. J. Psychiatry 178, 200-206 (2001).
4. Leveille, S.G., Buchner, D.M., Koepsell, T.D., McCloskey, L.W., Wolf, M.E. & Wagner, E.H. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5, 591-598 (1994).
5. Ray, W.A., Fought, R.L. & Decker, M.D. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am. J. Epidemiol. 136, 873-883 (1992).
6. Verster, J.C. & Ramaekers, J.G. (eds.). Antidepressants and Trafc Safety (Birkhaüser, Basel, Switzerland, 2009).
7. O'Hanlon, J.F., Robbe, H.W., Vermeeren, A., van Leeuwen, C. & Danjou, P.E. Venlafaxine's efects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fxed and incremental dosing regimens. J. Clin. Psychopharmacol. 18, 212-221 (1998).
8. Lane, R.M. & O'Hanlon, J.F. Cognitive and psychomotor efects of antidepressants with emphasis on selective serotonin reuptake inhibitors and the depressed elderly patient. Ger. J. Psychiatr. 2, 1-28 (1999).
9. Curkendall, S., Ruiz, K.M., Joish, V. & Mark, T.L. Productivity losses among treated depressed patients relative to healthy controls. J. Occup. Environ. Med. 52, 125-130 (2010).
10. Claxton, A.J., Chawla, A.J. & Kennedy, S. Absenteeism among employees treated for depression. J. Occup. Environ. Med. 41, 605-611 (1999).
11. Hindmarch, I. Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder. Int. J. Clin. Pract. 63, 1085-1094 (2009).
12. O'Hanlon, J.F., Haak, T.W., Blaauw, G.J. & Riemersma, J.B. Diazepam impairs lateral position control in highway driving. Science 217, 79-81 (1982).
13. Ramaekers, J.G., Uiterwijk, M.M. & O'Hanlon, J.F. Efects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur. J. Clin. Pharmacol. 42, 363-369 (1992).
14. Vuurman, E.F. et al. Efects of mefoquine alone and with alcohol on psycho-motor and driving performance. Eur. J. Clin. Pharmacol. 50, 475-482 (1996).
15. O'Hanlon, J.F., Brookhuis, K., Louwerens, J.W. & Volkerts, E.R. Performance testing as part of drug registration. In: Drugs and Driving (eds. O' Hanlon, J.F. & de Gier, J.J.) 311-327 (Taylor & Francis, London, 1986).
16. Wingen, M., Bothmer, J., Langer, S. & Ramaekers, J.G. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. J. Clin. Psychiatry 66, 436-443 (2005).
17. Ramaekers, J.G., Muntjewerf, N.D., Van Veggel, L.M.A., Uiterwijk, M.M.C. & O'Hanlon, J.F. Efects of nocturnal doses of mirtazapine and mianserin on sleep and on daytime psychomotor and driving performance in young, healthy volunteers. Hum. Psychopharmacol. Clin. Exp. 13, S87-S97 (1998).
18. Westrich, L. et al. In vitro and in vivo efects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets. Int. J. Psychiatr. Clin. Pract. 2012; 16 (suppl 1): 47.
19. Bang-Andersen, B. et al. Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl) phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J. Med. Chem. 54, 3206-3221 (2011).
20. Alvarez, E., Perez, V., Dragheim, M., Loft, H. & Artigas, F. A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. Int. J. Neuropsychopharmacol. 15, 589-600 (2012).
21. Katona, C., Hansen, T. & Olsen, C.K. A randomized, double-blind, placebo-controlled, duloxetine-referenced, fxed-dose study comparing the efcacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int. Clin. Psychopharmacol. 27, 215-223 (2012).
22. Anttila, S.A. & Leinonen, E.V. A review of the pharmacological and clinical profle of mirtazapine. CNS Drug Rev. 7, 249-264 (2001).
23. Nutt, D.J. Tolerability and safety aspects of mirtazapine. Hum. Psychopharmacol. 17(suppl. 1), S37-S41 (2002).
24. Ridout, F., Meadows, R., Johnsen, S. & Hindmarch, I. A placebo controlled investigation into the efects of paroxetine and mirtazapine on measures related to car driving performance. Hum. Psychopharmacol. 18, 261-269 (2003).
25. Louwerens, J.W., Gloerich, A.B.M, de Vries, G., Brookhuis, K.A. & O'Hanlon, J.F. The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. International Conference on Alcohol, Drugs and Trafc Safety, T86 (eds. Noordzij, P.C. & Roszbach, R.), Amsterdam, The Netherlands, 9-12 September 1986. 183-186.
26. Ramaekers, J.G. et al. Residual efects of esmirtazapine on actual driving performance: overall fndings and an exploratory analysis into the role of CYP2D6 phenotype. Psychopharmacology (Berl.) 215, 321-332 (2011).
27. Ramaekers, J.G., Ansseau, M., Muntjewerf, N.D., Sweens, J.P. Noordzij, P.C. & O'Hanlon, J.F. Considering the P450 cytochrome system as determining combined efects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients. Int. Clin. Psychopharmacol. 12, 159-169 (1997).
28. Ramaekers, J.G., Swijgman, H.F. & O'Hanlon, J.F. Efects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacology (Berl.) 106(suppl.), S62-S67 (1992).
29. Ramaekers, J.G., Muntjewerf, N.D. & O'Hanlon, J.F. A comparative study of acute and subchronic efects of dothiepin, fuoxetine and placebo on psychomotor and actual driving performance. Br. J. Clin. Pharmacol. 39, 397-404 (1995).
30. Robbe, H.W. & O'Hanlon, J.F. Acute and subchronic efects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur. Neuropsychopharmacol. 5, 35-42 (1995).
31. van Laar, M.W., van Willigenburg, A.P. & Volkerts, E.R. Acute and subchronic efects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J. Clin. Psychopharmacol. 15, 30-40 (1995).
32. Moore, N. et al. P. 2. b. 015 Lu AA21004: a novel potential treatment for mood disorders. Eur. Neuropsychopharmacol. 18, S321 (2008).
33. Mørk, A. et al. Pharmacological efects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. J. Pharmacol. Exp. Ther. 340, 666-675 (2012).
34. Theunissen, E.L., Vermeeren, A., van Oers, A.C., van Maris, I. & Ramaekers, J.G. A dose-ranging study of the efects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Clin. Exp. Allergy 34, 250-258 (2004).
35. Jex, H.R., McDonnell, J.D. & Phatak, A.V. A "critical" tracking task for man-machine research related to the operator's efective delay time. I. Theory and experiments with a frst-order divergent controlled element. NASA CR-616. NASA Contract. Rep. NASA CR. 1-105 (1966).
36. Theunissen, E.L., Vermeeren, A. & Ramaekers, J.G. Repeated-dose efects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br. J. Clin. Pharmacol. 61, 79-86 (2006).
37. Moskowitz, H. Laboratory studies of the efects of alcohol on some variables related to driving. J. Safety. Res. 5, 185-92 (1973).
38. Rey, A. L'examen Clinique en Psychologie. (Presses Universitaires de France, Paris, France, 1964).
39. Dinges, D. & Powell, J. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav. Res. Meth. 17, 652-5 (1985).
40. Mulder-Hajonides van der Meulen, W.R.E.H. Measurements of subjective sleep quality. Proceedings of the International European Sleep Conference (Elsevier, Amsterdam, The Netherlands, 1981).
41. Areberg, J., Søgaard, B. & Højer, A.M. The clinical pharmacokinetics of Lu AA21004 and its major metabolite in healthy young volunteers. Basic Clin. Pharmacol. Toxicol. 111, 198-205 (2012).